Flexible Conductive Hearing Aids for Conductive Hearing Loss
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a new flexible hearing aid for individuals with conductive hearing loss, where sound struggles to move through the outer or middle ear. The study will evaluate how this hearing aid improves hearing ability compared to current aids or no aid at all. It suits those diagnosed with conductive or mixed hearing loss, whether they already use hearing aids or are considering ear surgeries. Healthy individuals without hearing loss can also participate to help simulate the condition. As an unphased trial, participants contribute to groundbreaking research that may lead to innovative hearing solutions.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this flexible conductive hearing aid is safe for use in conductive hearing loss?
Research has shown that flexible conductive hearing aids are safe. These devices offer a non-invasive solution for conductive hearing loss. Studies have found that users generally tolerate them well, with no reports of serious side effects. Unlike hearing aids requiring implantation, these flexible ones do not need surgery, reducing potential risks. This makes them a promising choice for both children and adults with conductive hearing loss.12345
Why are researchers excited about this trial?
Unlike traditional hearing aids that can be bulky and uncomfortable, the Flexible Conductive Hearing Aid is designed like a Band-Aid, offering a more comfortable and discreet option for those with conductive hearing loss. This innovative device works by directly conducting sound through the skin, bypassing the damaged parts of the ear, which is a different approach compared to conventional hearing aids that amplify sound. Researchers are excited about this treatment because it promises to improve sound quality and user comfort, potentially making it a game-changer for individuals who struggle with the limitations of existing hearing aid technology.
What evidence suggests that this flexible conductive hearing aid is effective for conductive hearing loss?
Research shows that flexible conductive hearing aids, tested in this trial, can help people with conductive hearing loss hear better. These aids create vibrations on the skin to improve sound transmission, bypassing ear problems. Early studies suggest that this type of hearing aid greatly improves the ability to hear quiet sounds in both children and adults with conductive hearing loss. This noninvasive method is especially promising for children, offering a new way to manage permanent hearing loss from birth conditions like underdeveloped outer ears or ear bones. Overall, evidence supports that flexible conductive hearing aids significantly enhance hearing ability.12367
Who Is on the Research Team?
Mohammad Moghimi, PhD
Principal Investigator
Wake Forest University Health Sciences
Are You a Good Fit for This Trial?
This trial is for pregnant women, infants, children, adolescents, and adults diagnosed with conductive or mixed hearing loss. It includes those who may already use hearing aids or are candidates for certain types of hearing aid surgery. Healthy individuals without hearing loss can also participate. Adults unable to understand the study details or unwilling to participate are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assessed for hearing thresholds before and during the use of the flexible Band-Aid style hearing device
Follow-up
Participants are monitored for any changes in hearing thresholds and device effectiveness after initial use
What Are the Treatments Tested in This Trial?
Interventions
- Flexible Conductive Hearing Aid
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor